News
A daily pill developed by the US pharmaceutical company Lilly may become a convenient alternative to injectable drugs like ...
Christopher Schwarzenegger — the youngest child of Arnold Schwarzenegger and Maria Shriver — stepped out with his brother ...
Pharmaceutical giant Eli Lilly (LLY) surged 14% last week to $840 per share following positive Phase 3 trial results for its ...
SkinnyTok creators say they only preach tough love. Experts say its harmful content disguised with a cute name ...
DEAR PEOPLE’S PHARMACY: I’ve been on Ozempic for several months now. My blood sugar in the morning is around 103, down from ...
A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...
1d
USA TODAY College Sports Wire on MSNOregon Football’s Dave Iuli focuses on weight loss to elevate 2025 impactOregon Ducks veteran guard Dave Iuli has focused on losing weight and slimming down ahead of a potential breakout season in ...
Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...
A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...
Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...
Drizzled over fruit and yogurt, blended into smoothies, or baked into breakfast muffins, honey makes a lot of things in life ...
In 2024, the FDA's Center for Drug Evaluation and Research (CDER) approved 50 new drugs. The CDER director, Patrizia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results